Amplify Weight Loss Drug & Treatment ETF (THNR) is an exchange-traded fund (ETF) listed on the New York Stock Exchange Arca. It pays a current dividend yield of 1.63% ($0.41 per share annually (TTM)). The most recent ex-dividend date was December 30, 2025, with payment scheduled for December 31, 2025. market capitalization is approximately $5M. Review THNR dividend history on this scorecard, compare peers in the Compare Dividend Returns tool, or project income with the dividend calculator.
THNR holds 20 positions, with 62.9% of assets in its ten largest. It charges an expense ratio of 0.59%, and manages $5.8M.
| Holding | Weight |
|---|---|
| NVONovo Nordisk A/S | 9.09% |
| LLYEli Lilly & Co | 8.55% |
| REGNRegeneron Pharmaceuticals Inc | 6.36% |
| 1801.HKInnovent Biologics Inc | 6.15% |
| AMGNAmgen Inc | 5.71% |
| 1093.HKCSPC Pharmaceutical Group Ltd | 5.65% |
| MRKMerck & Co Inc | 5.57% |
| SRRKScholar Rock Holding Corp | 5.56% |
| ABBVAbbVie Inc | 5.16% |
| ARWRArrowhead Pharmaceuticals Inc | 5.08% |